Jia Jie Biomedical Co., Ltd.

TPEX:4109 Voorraadrapport

Marktkapitalisatie: NT$2.5b

Jia Jie Biomedical Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Wen-Fang Hsieh

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

How Much Did Jia Jie Biomedical's(GTSM:4109) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 21
How Much Did Jia Jie Biomedical's(GTSM:4109) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO

Wen-Fang Hsieh

less than a year

Tenure

Wen-Fang Hsieh is Chief Executive Officer of Jia Jie Biomedical Co. Ltd. from January 16, 2024.